// App-Quantinova.ai

P579 : Complete disease resolution after allogenic hematopoietic stem cell transplantation in children with very early onset inflammatory disease and no identified monogenic mutation

Researchers

Presenter

  • A. Zambrano Perez

Principal Investigators

  • M. Elawad

  • F. Kiparissi

  • N. Shah

  • S. Chadokufa

  • S. Sider

  • B. Huggett

Medical Centers

  • Great Ormond Street Hospital for Children, Department of Gastroenterology, London, United Kingdom

  • Sidra Medical and Research Center, Inflammatory Bowel Disorders Section, Doha, Qatar

Locations

  • United Kingdom

  • Qatar

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Basiliximab

  • Adalimumab

  • Infliximab

  • Hydroxyzine

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved